Compounds > 1,4,7-triazacyclononane-n,n',n''-triacetic acid
Page last updated: 2024-09-03

1,4,7-triazacyclononane-n,n',n''-triacetic acid and Multiple Myeloma

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Multiple Myeloma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Deng, Y; He, L; Wang, H; Zhang, W1
An, S; Chen, Y; Hou, J; Hou, YN; Huang, G; Li, L; Liu, J; Liu, Q; Wang, C; Wei, W; Zhang, D; Zhang, Y; Zhao, H; Zhao, YJ1
Bailly, C; Bourgeois, M; Bris, NL; Chérel, M; Faivre-Chauvet, A; Le Bihan, T; Le Saëc, P; Navarro, AS; Saï-Maurel, C; Tripier, R1

Other Studies

3 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Multiple Myeloma

ArticleYear
Renal Interstitial Fibrosis Detected on 18F-AlF-NOTA-FAPI-04 PET/CT in a Patient With Multiple Myeloma.
    Clinical nuclear medicine, 2023, Oct-01, Volume: 48, Issue:10

    Topics: Biopsy, Fine-Needle; Female; Fibrosis; Humans; Kidney Diseases; Middle Aged; Multiple Myeloma; Positron Emission Tomography Computed Tomography

2023
ImmunoPET imaging of multiple myeloma with [
    European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:9

    Topics: Cell Line, Tumor; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Multiple Myeloma; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed

2021
TE1PA as Innovating Chelator for
    Bioconjugate chemistry, 2019, 09-18, Volume: 30, Issue:9

    Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Chelating Agents; Copper Radioisotopes; Heterocyclic Compounds, 1-Ring; Immunoconjugates; Mice; Multiple Myeloma; Positron-Emission Tomography; Tissue Distribution

2019